These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Myoclonic encephalopathy caused by bismuth]. Gómez Jiménez J; Alvarez J; Boada Rovira M; Codina-Puiggros A Rev Clin Esp; 1989 Mar; 184(4):212. PubMed ID: 2740555 [No Abstract] [Full Text] [Related]
34. [Myoclonic encephalopathy due to bismuth subnitrate. A recent case]. Goas JY; Borsotti JP; Missoum A; Allain P; Chaleil D Nouv Presse Med; 1981 Dec; 10(47):3855. PubMed ID: 7329800 [No Abstract] [Full Text] [Related]
35. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Burns R; Thomas DW; Barron VJ Br Med J; 1974 Feb; 1(5901):220-3. PubMed ID: 4818163 [TBL] [Abstract][Full Text] [Related]
36. [Encephalopathy during oral treatment with bismuth salts]. Michaud PA; Regli F Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634 [TBL] [Abstract][Full Text] [Related]
37. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment]. Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823 [No Abstract] [Full Text] [Related]